An international study found that finerenone slows kidney function decline and reduces the risk of serious kidney and ...
Morning Overview on MSN
The FDA cleared the first drug shown to slow a kidney disease that silently scars the organ
Adults and children living with a rare kidney-scarring condition called focal segmental glomerulosclerosis now have the first ...
Finerenone belongs to a class of medications known as mineralocorticoid receptor antagonists. It works by blocking pathways that contribute to inflammation and scarring in the kidneys and heart.
New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...
Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with chronic kidney disease and uncontrolled high ...
A trio of major studies found that finerenone may protect the kidneys and heart in far more people than previously thought. The drug significantly slowed kidney disease progression and reduced the ...
Approximately 35 million adults in the United States suffer from chronic kidney disease (CKD), and that number is growing. Meanwhile, there’s a critical shortage of nephrologists to manage these ...
A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems over time. Researchers followed nearly 300,000 patients for up to 15 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results